Related Experiment Video
Updated: May 27, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Are Gabapentinoids Effective at Reducing Pain and Improving Sleep After Nerve Injury? A Systematic Review and
Ebubechi K Adindu1, Nienke A Krijnen2,3, Sierra N Short4
1Department of Orthopaedic Surgery, the University of Texas at Austin, Austin, TX, USA.
Gabapentinoids do not effectively reduce pain or improve sleep in peripheral nerve injuries. This meta-analysis of randomized controlled trials suggests these drugs should not be prescribed for these conditions.
Area of Science:
- Neurology
- Pharmacology
- Pain Management
Background:
- Gabapentinoids are frequently prescribed off-label for peripheral nerve injury pain and sleep disturbances.
- Randomized controlled trials (RCTs) show conflicting results, and crossover designs risk unblinding.
- Concerns over side effects and misuse necessitate a review of the best available evidence.
Purpose of the Study:
- To determine if gabapentinoids are superior to placebo in reducing pain intensity.
- To assess if gabapentinoids effectively mitigate sleep disruption in patients with peripheral nerve injuries.
Main Methods:
- Meta-analysis of four randomized controlled trials (RCTs) including 919 patients with peripheral nerve injuries.
- Searched PubMed, Embase, and Cochrane Library for RCTs from January 2000 to January 2022.
- Excluded crossover trial data post-intervention to prevent unblinding; assessed risk of bias as low.
Main Results:
- Gabapentinoids showed no significant pain reduction compared to placebo at 1 month (p=0.40) or 2-4 months (p=0.05).
- No clinically significant difference in sleep interference was observed between gabapentinoids and placebo at 2-4 months (p<0.01).
- Moderate certainty of evidence (GRADE) was established, with limitations due to indirectness.
Conclusions:
- Current evidence suggests gabapentinoids are not effective for pain or sleep issues in peripheral nerve injuries.
- Given common side effects and misuse potential, their use for these indications is not recommended.
- Further research may be needed, but existing high-quality RCTs do not support their efficacy.
More Related Videos
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...